6 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 6, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Ipratropium Bromide: new trials by email Literature Review of Ipratropium Bromide trials Research Report on Ipratropium Bromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD) Revefenacin, formoterol fumarate, Placebo (Sterile Normal Saline) - COPD Exacerbation | Phase 4 | Not yet recruiting | University of Tennessee Graduate School of Medicine | 280 | 2026-11-12 | 2026-10-19 |
| Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation Nebulized Magnesium Sulfate, Nebulized isotonic saline, Nebulized Salbutamol - Asthma | Phase 4 | Unknown | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | 152 | 2015-09-01 | 2015-12-02 |
| Ipratropium Bromide in Peri-Operative COPD placebo, ipratropium bromide - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | Boehringer Ingelheim | 192 | 2013-10-01 | 2016-10-25 |
| Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes ipratropium bromide, Placebo - Bronchospasm, Exercise-Induced | Phase 4 | Completed | University of California, San Francisco | 20 | 2012-12-01 | 2020-06-05 |
| Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients Salbutamol, ipratropium bromide - COPD | Phase 4 | Completed | University Hospital, Antwerp | 6 | 2008-06-01 | 2009-06-02 |
| Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness ipratropium bromide, placebo - Asthma | Phase 4 | Completed | University of Saskatchewan | 12 | 2008-01-01 | 2009-01-07 |
| Budesonide Inhalation Suspension for Acute Asthma in Children Budesonide inhalation suspension (0.5 mg/2mL) 2mg, albuterol (5mg/mL) 7.5 or 10mg, Prednisolone, prednisone, or methylprednisolone, Albuterol, ipratropium bromide - Asthma, Acute Asthma | Phase 4 | Completed | Children's Hospital of Philadelphia | 179 | 2006-12-01 | 2012-08-10 |
| Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD) Ipratropium Bromide - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Queen's University | 32 | 2005-07-01 | 2011-04-19 |
| Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children Ipratropium bromide, Placebo, Salbutamol - Asthma | Phase 4 | Terminated | Boehringer Ingelheim | 3 | 1998-09-01 | 2014-09-10 |
Asthma (4) · Pulmonary Disease, Chronic Obstructive (3) · Asthma, Exercise-Induced (1) · Bronchiolitis Obliterans Syndrome (1) · Disease (1) · Dyspnea (1) · Emergencies (1) · Motor Activity (1)
Boehringer Ingelheim (2) · Children's Hospital of Philadelphia (1) · Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1) · Queen's University (1) · University Hospital, Antwerp (1) · University of California, San Francisco (1) · University of Saskatchewan (1) · University of Tennessee Graduate School of Medicine (1)
United States (3) · Canada (2) · Belgium (1) · China (1) · Mexico (1)
Bryan D. Upham, M.D. (1) · Cynthia J Mollen, M.D. (1) · Denis E O'Donnell, MD (1) · Donald W Cockcroft, MD (1) · Mona Luke-Zeitoun (1) · Wilfried A De Backer, MD PhD (1)